Clinical Trial Update: Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant [Phase 2]

View source ↗

Summary

A multicenter, randomized Phase 2 pharmacokinetic study comparing LCP-Tacro to Prograf capsules in de novo adult kidney transplant recipients; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Failure

Drugs mentioned

• LCP-Tacro (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-07-07